Literature DB >> 9006748

Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. "Tomudex" Colorectal Cancer Study Group.

D Cunningham1, J R Zalcberg, U Rath, I Oliver, E van Cutsem, C Svensson, J F Seitz, P Harper, D Kerr, G Perez-Manga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9006748     DOI： 10.1093/oxfordjournals.annonc.a010800

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  32 in total

Review 1.  Management of chemotherapy-induced adverse effects in the treatment of colorectal cancer.

Authors:  F G Jansman; D T Sleijfer; J C de Graaf; J L Coenen; J R Brouwers
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Raltitrexed (tomudex) administration in patients failing multiple prior chemotherapy regimens in advanced colorectal cancer: a pilot study.

Authors:  N Tsavaris; C Kosmas; M Vadiaka; A Kontos; M Fotia; A Angelopoulou; N Vrizidis; M Soulla; S Sougioultzis; Ch Koufos
Journal:  Invest New Drugs       Date:  2002-02       Impact factor: 3.850

Review 3.  Risk factors determining chemotherapeutic toxicity in patients with advanced colorectal cancer.

Authors:  F G Jansman; D T Sleijfer; J L Coenen; J C De Graaf; J R Brouwers
Journal:  Drug Saf       Date:  2000-10       Impact factor: 5.606

Review 4.  Progress in colorectal cancer chemotherapy: how far have we come, how far to go?

Authors:  M E Royce; P M Hoff; R Pazdur
Journal:  Drugs Aging       Date:  2000-09       Impact factor: 3.923

Review 5.  Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies.

Authors:  C R Culy; D Clemett; L R Wiseman
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

Review 6.  Role of chemotherapy and novel biological agents in the treatment of elderly patients with colorectal cancer.

Authors:  Gerardo Rosati; Domenico Bilancia
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

Review 7.  First-line treatment strategies to improve survival in patients with advanced colorectal cancer.

Authors:  Sharlene Gill; Richard M Goldberg
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 8.  Colorectal cancer in the elderly: is palliative chemotherapy of value?

Authors:  Friedemann Honecker; Claus-Henning Köhne; Carsten Bokemeyer
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

9.  Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases.

Authors:  N C Tebbutt; A R Norman; D Cunningham; M E Hill; D Tait; J Oates; S Livingston; J Andreyev
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

10.  Population pharmacokinetics of raltitrexed in patients with advanced solid tumours.

Authors:  Elaine Y L Blair; Laurent P Rivory; Stephen J Clarke; Andrew J McLachlan
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.